FGFR alterations in pediatric cancers: Opportunity for targeted therapy

被引：0
|
作者：
LI, Ivan
Huo, Yuchen
Li, Gary
Zage, Peter
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2023年 / 22卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-23-A165
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A165
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Enhancing targeted therapy of tumors with activating FGFR alterations.
    Bockorny, Bruno
    Rusan, Maria
    Piccioni, Federica
    Tan, Li
    Bass, Adam Joel
    Hammerman, Peter S.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] Protein neddylation and its alterations in human cancers for targeted therapy
    Zhou, Lisha
    Zhang, Wenjuan
    Sun, Yi
    Jia, Lijun
    CELLULAR SIGNALLING, 2018, 44 : 92 - 102
  • [3] TARGETED THERAPY FOR MAPK PATHWAY ALTERATIONS IN PEDIATRIC TUMORS
    Suthar, Jugal
    Taylor, Alaric
    Berry, Philip
    Veal, Gareth
    Guldin, Stefan
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S619 - S620
  • [4] THE INFLUENCE OF DIFFERENT FGFR1 ALTERATIONS ON PEDIATRIC LOW-GRADE GLIOMA TUMOR BIOLOGY AND TARGETED THERAPY RESPONSE
    Morin, Eric
    DiGiacomo, Jeromy
    Novikov, Dana
    Malinowski, Seth
    Chow, Kin-Hoe
    Jones, David
    Alexandrescu, Sanda
    Ligon, Keith
    Bandopadhayay, Pratiti
    NEURO-ONCOLOGY, 2022, 24 : 99 - 99
  • [5] LANDSCAPE OF FGFR ALTERATIONS IN PEDIATRIC AND AYA GLIOMAS
    Nobre, Liana
    Sait, Sameer Farouk
    Bennet, Julie
    Larsen, Alexandra Gianyini
    Ho, I-Chen
    Gianno, Francesca
    Lin, Andrew
    Mellinghoff, Ingo
    Miller, Alexandra
    Siddaway, Robert
    Karijannis, Matthias
    Tabori, Uri
    Bale, Tejus
    Hawkins, Cynthia
    NEURO-ONCOLOGY, 2023, 25
  • [6] A potent FGFR4-targeted antibody-drug conjugate therapy for patients with rhabdomyosarcoma and other cancers expressing FGFR4
    Tian, Meijie
    Jia, Katrina
    Wu, Jerry T.
    Wei, Jun S.
    Cheuk, Adam T.
    Zhang, Zhongmei
    Pope, Eleanor G.
    Shor, Boris
    Tumey, L. Nathan
    Khan, Javed
    CANCER RESEARCH, 2024, 84 (07)
  • [7] Overexpression of B7-H3 as an opportunity for targeted therapy in head and neck cancers
    Hu, Juanjuan
    Jiang, Caiying
    Zheng, Meijun
    Guo, Yuxin
    Tang, Xin
    Ren, Jia
    Lu, Dan
    Yu, Lingyu
    Gan, Weigang
    Liu, Shixi
    Tong, Aiping
    Yang, Hui
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (08): : 5183 - 5196
  • [8] Comprehensive characterization of FGF/FGFR alterations in invasive breast cancers.
    Gaur, Kush C.
    Tiu-Lim, Justin
    McGrath, Julie
    Walker, Phil
    Korn, Michael
    Xiu, Joanne
    Heeke, Arielle
    Kaklamani, Virginia
    Tan, Antoinette
    Lu, Janice
    Spicer, Darcy
    Roussos-Torres, Evanthia
    Jayachandran, Priya
    Saghian, Audrey
    Goldkorn, Amir
    Kang, Irene
    CANCER RESEARCH, 2022, 82 (12)
  • [9] FGFR1-3 Alterations in Cholangiocarcinoma, Urothelial, and Other Cancers
    Udhane, S.
    Alyaqoub, F.
    Barbi, M.
    Chandrasekaran, T.
    Dogruluk, T.
    Dombrowski, S.
    Driscoll, D.
    Hong, L.
    Jalkanen, A.
    Noel, P.
    Szelinger, S.
    Wang, M.
    Hall, D.
    Hoag, J.
    Baehner, F.
    Routh, J.
    Thakkar, S.
    Lobello, J.
    Basu, G.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (10): : S14 - S14
  • [10] Fibroblast Growth Factor Receptor (FGFR) Alterations in HPV Oropharyngeal Cancers
    Bhateja, Priyanka
    Liu, Xuefeng
    Baliga, Sujith
    Gogineni, Emile
    Jhawar, Sachin
    Mitchell, Darrion
    Ma, Sungjun
    Zhu, Simeng
    Konieczkowski, David
    Blakaj, Dukagjin
    Old, Matthew
    Rocco, James
    Bonomi, Marcelo
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (11)
12345